ADVFN Logo ADVFN

Hot Features

Registration Strip Icon for charts 登録してリアルタイムのチャート、分析ツール、価格を入手してください。
Chiasma Inc

Chiasma Inc (CHMA)

3.76
0.00
(0.00%)
終値: 1月6日 6:00AM
3.76
0.00
( 0.00% )
取引時間後: -

リアルタイムのディスカッションと取引のアイデア: 当社の強力なプラットフォームで自信を持って取引できます。

主要統計と詳細

通貨
3.76
買値
3.76
売値
3.80
出来高
-
0.00 日の範囲 0.00
0.00 52 週間の範囲 0.00
前日終値
3.76
始値
-
時刻
最終取引時間
-
平均取引量 (3 か月)
-
財務取引量
-
VWAP
-

CHMA 最新ニュース

Pulmatrix appoints Director Anand Varadan

Pulmatrix appoints Director Anand Varadan PR Newswire LEXINGTON, Mass., July 27, 2021 LEXINGTON, Mass., July 27, 2021 /PRNewswire/ -- Pulmatrix, Inc. (NASDAQ: PULM), a clinical-stage...

ALERT: Rowley Law PLLC is Investigating Proposed Acquisition of Chiasma, Inc.

ALERT: Rowley Law PLLC is Investigating Proposed Acquisition of Chiasma, Inc. PR Newswire NEW YORK, May 5, 2021 NEW YORK, May 5, 2021 /PRNewswire/ -- Rowley Law PLLC is investigating potential...

Chiasma Announces Pricing of a Public Offering of $70 Million of Common Stock and Pre-Funded Warrants

NEEDHAM, Mass., July 01, 2020 (GLOBE NEWSWIRE) -- Chiasma, Inc. (NASDAQ: CHMA), a commercial biopharmaceutical company focused on developing and commercializing oral therapies utilizing its...

Chiasma Announces Proposed Public Offering of Common Stock and Pre-Funded Warrants

NEEDHAM, Mass., June 30, 2020 (GLOBE NEWSWIRE) -- Chiasma, Inc. (NASDAQ: CHMA), a commercial biopharmaceutical company focused on developing and commercializing oral therapies utilizing its...

Chiasma Announces FDA Approval of MYCAPSSA® (Octreotide) Capsules, the First and Only Oral Somatostatin Analog

MYCAPSSA is indicated for long-term maintenance treatment in acromegaly patients who have responded to and tolerated treatment with octreotide or lanreotide Conference call and webcast scheduled...

Chiasma Reports First Quarter 2020 Financial Results

NEEDHAM, Mass., May 07, 2020 (GLOBE NEWSWIRE) -- Chiasma, Inc. (NASDAQ: CHMA), a clinical, late-stage biopharmaceutical company focused on improving the lives of patients who face challenges...

Chiasma To Report First Quarter Financial Results On May 7, 2020

NEEDHAM, Mass., April 30, 2020 (GLOBE NEWSWIRE) -- Chiasma, Inc. (NASDAQ: CHMA), a clinical, late-stage biopharmaceutical company focused on improving the lives of patients with rare and serious...

Chiasma Appoints Anand Varadan as Chief Commercial Officer and Reports Inducement Grant under NASDAQ Listing Rule 5635(c)(4)

NEEDHAM, Mass., April 22, 2020 (GLOBE NEWSWIRE) -- Chiasma, Inc. (NASDAQ: CHMA), a clinical, late stage biopharmaceutical company focused on improving the lives of patients who face challenges...

Chiasma Enters Into Revenue Interest Financing Agreement for up to $75 Million with Healthcare Royalty Partners

NEEDHAM, Mass., April 08, 2020 (GLOBE NEWSWIRE) -- Chiasma, Inc. (NASDAQ: CHMA), a clinical, late-stage biopharmaceutical company focused on improving the lives of patients with rare and serious...

Chiasma Reports Fourth Quarter and Full Year 2019 Financial Results

MYCAPSSA® PDUFA Date Set for June 26, 2020; U.S. Commercial Launch Planned in Q4’20 First Industry Sponsored U.S. Disease State Registry for Acromegaly Began Enrolling Patients NEEDHAM, Mass...

期間 †前日比前日比 %始値高値安値平均出来高VWAP
10000000CS
40000000CS
120000000CS
260000000CS
520000000CS
1560000000CS
2600000000CS

CHMA - Frequently Asked Questions (FAQ)

What is the current Chiasma share price?
The current share price of Chiasma is US$ 3.76
What is the 1 year trading range for Chiasma share price?
Chiasma has traded in the range of US$ 0.00 to US$ 0.00 during the past year

ムーバー

すべて表示
  • 出来高
  • 値上がり率
  • 値下がり率
銘柄コード株価出来高
HUBCWHub Cyber Security Ltd
US$ 0.0639
(59.75%)
300
MEGLMagic Empire Global Limited
US$ 0.866
(54.07%)
4.6M
PTLEPTL Ltd
US$ 11.30
(52.91%)
128.6k
FCUVFocus Universal Inc
US$ 1.2901
(34.53%)
11.23M
VEEETwin Vee PowerCats Company
US$ 0.6627
(34.42%)
7.17M
ACONAclarion Inc
US$ 0.20
(-32.98%)
12.79M
BCTXBriaCell Therapeutics Corporation
US$ 0.50
(-21.96%)
482.53k
NITON2OFF Inc
US$ 2.23
(-15.53%)
3.36M
RAINRain Enhancement Technologies Holdco Inc
US$ 5.05
(-13.53%)
20.82k
SYTASiyata Mobile Inc
US$ 6.08
(-10.46%)
164.95k
CNSPCNS Pharmaceuticals Inc
US$ 0.1529
(24.31%)
19.68M
QSIQuantum Si Inc
US$ 3.91
(-8.86%)
14.38M
ACONAclarion Inc
US$ 0.20
(-32.98%)
12.79M
FCUVFocus Universal Inc
US$ 1.2901
(34.53%)
11.23M
KITTNauticus Robotics Inc
US$ 4.72
(24.21%)
10.04M

CHMA Discussion

投稿を表示

最近閲覧した銘柄

Delayed Upgrade Clock